脓毒症诱导急性呼吸窘迫综合征中蛋白生物标志物的连续测量
这项前瞻性观察性队列研究纳入111例入住内科ICU且脓毒症诊断72小时内的成人患者,连续3天测量血浆sRAGE、血管生成素-2和SP-D水平,主要终点为ARDS发生,次要终点为28天死亡。21例(18.9%)发生ARDS,三种标志物在ARDS与非ARDS患者3天测量中均无显著差异;死亡者多个时间点三种标志物均高于存活者;标志物随时间变化在结局组间无差异。第1天SP-D水平与死亡相关(OR 1.52,95%CI 1.03-2.24,p=0.03),血管生成素-2水平与死亡相关(估计值0.0002,标准误0.0001,p=0.04)。
要点
- 在脓毒症成人患者中,ARDS组与非ARDS组连续3天血浆sRAGE、血管生成素-2和SP-D水平均无显著差异。
- 死亡者多个测量日三种标志物水平均高于存活者,但标志物随时间变化在结局组间无差异。
- 第1天SP-D水平与死亡相关:OR 1.52(95%CI 1.03-2.24,p=0.03)。
- 血管生成素-2水平与死亡相关:估计值0.0002(标准误0.0001,p=0.04)。
- 作者认为ARDS患者中sRAGE和SP-D(而非血管生成素-2)有升高趋势,可能提示上皮损伤在脓毒症诱导ARDS中的重要性。
适用人群与场景
- 纳入脓毒症诊断72小时内入住内科ICU的成人患者;研究在Grady Memorial Hospital内科ICU进行。
研究设计与关键结果
- 研究设计:前瞻性观察性队列研究,纳入111例脓毒症成人患者,其中21例(18.9%)发生ARDS。
- 主要终点:ARDS发生;次要终点:28天死亡。
- 血浆sRAGE、血管生成素-2、SP-D在入组后连续3天测量;三种标志物在ARDS与非ARDS患者3天测量中均无显著差异。
- 死亡者多个测量日三种标志物水平均高于存活者;标志物随时间变化在结局组间无差异。
- 逻辑回归显示第1天SP-D水平与死亡相关:OR 1.52(95%CI 1.03-2.24,p=0.03)。
- 广义估计方程显示血管生成素-2水平与死亡相关:估计值0.0002(标准误0.0001,p=0.04)。
- 作者认为ARDS患者中sRAGE和SP-D(而非血管生成素-2)有升高趋势,可能提示上皮损伤在脓毒症诱导ARDS中的重要性。
证据类型、等级与局限
- 证据类型:前瞻性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: The role of early, serial measurements of protein biomarkers in sepsis-induced acute respiratory distress syndrome (ARDS) is not clear.
OBJECTIVES: To determine the differences in soluble receptor for advanced glycation end-products (sRAGEs), angiopoietin-2, and surfactant protein-D (SP-D) levels and their changes over time between sepsis patients with and without ARDS.
DESIGN SETTING AND PARTICIPANTS: Prospective observational cohort study of adult patients admitted to the medical ICU at Grady Memorial Hospital within 72 hours of sepsis diagnosis.
MAIN OUTCOMES AND MEASURES: Plasma sRAGE, angiopoietin-2, and SP-D levels were measured for 3 consecutive days after enrollment. The primary outcome was ARDS development, and the secondary outcome of 28-day mortality. The biomarker levels and their changes over time were compared between ARDS and non-ARDS patients and between nonsurvivors and survivors.
RESULTS: We enrolled 111 patients, and 21 patients (18.9%) developed ARDS. The three biomarker levels were not significantly different between ARDS and non-ARDS patients on all 3 days of measurement. Nonsurvivors had higher levels of all three biomarkers than did survivors on multiple days. The changes of the biomarker levels over time were not different between the outcome groups. Logistic regression analyses showed association between day 1 SP-D level and mortality (odds ratio, 1.52; 95% CI, 1.03-2.24; p = 0.03), and generalized estimating equation analyses showed association between angiopoietin-2 levels and mortality (estimate 0.0002; se 0.0001; p = 0.04).
CONCLUSIONS AND RELEVANCE: Among critically ill patients with sepsis, sRAGE, angiopoietin-2, and SP-D levels were not significantly different between ARDS and non-ARDS patients but were higher in nonsurvivors compared with survivors. The trend toward higher levels of sRAGE and SP-D, but not of angiopoietin-2, in ARDS patients may indicate the importance of epithelial injury in sepsis-induced ARDS. Changes of the biomarker levels over time were not different between the outcome groups.
参考来源
- Yang P, Iffrig E, Harris F, et al. Serial Measurements of Protein Biomarkers in Sepsis-Induced Acute Respiratory Distress Syndrome. Crit Care Explor. 2022. PMID: 36284549. doi:10.1097/CCE.0000000000000780
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。